Cytek Biosciences, Inc. (CTKB)
Largest Insider Buys in Sector
CTKB Stock Price History Chart
CTKB Stock Performance
About Cytek Biosciences, Inc.
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The …
Insider Activity of Cytek Biosciences, Inc.
Over the last 12 months, insiders at Cytek Biosciences, Inc. have bought $0 and sold $638,224 worth of Cytek Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Cytek Biosciences, Inc. have bought $92.6M and sold $5.48M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 241,727 shares for transaction amount of $2.96M was made by RA CAPITAL MANAGEMENT, L.P. (director, 10 percent owner) on 2022‑03‑15.
List of Insider Buy and Sell Transactions, Cytek Biosciences, Inc.
| 2024-04-19 | Sale | CHIEF TECHNOLOGY OFFICER | 20,000 0.0152% | $5.87 | $117,400 | -4.31% | ||
| 2024-04-09 | Sale | CHIEF TECHNOLOGY OFFICER | 1,900 0.0015% | $7.00 | $13,304 | -17.85% | ||
| 2024-03-19 | Sale | CHIEF TECHNOLOGY OFFICER | 20,000 0.0153% | $6.71 | $134,200 | -13.36% | ||
| 2024-03-18 | Sale | CHIEF TECHNOLOGY OFFICER | 20,000 0.0152% | $6.77 | $135,400 | -14.56% | ||
| 2023-12-26 | Sale | Chief Financial Officer | 3,000 0.0022% | $9.50 | $28,500 | -34.91% | ||
| 2023-12-19 | Sale | Chief Technology Officer | 20,000 0.0147% | $9.43 | $188,600 | -34.67% | ||
| 2023-11-24 | Sale | Chief Financial Officer | 3,000 0.0022% | $6.94 | $20,820 | -8.94% | ||
| 2023-11-20 | Sale | Chief Technology Officer | 20,000 0.0146% | $6.03 | $120,600 | +5.29% | ||
| 2023-11-07 | Sale | President and CEO | 20,000 0.0143% | $4.34 | $86,800 | +41.44% | ||
| 2023-10-24 | Sale | Chief Financial Officer | 3,000 0.0022% | $4.68 | $14,040 | +30.74% | ||
| 2023-10-19 | Sale | Chief Technology Officer | 20,000 0.0149% | $4.80 | $96,000 | +31.08% | ||
| 2023-10-09 | Sale | President and CEO | 20,000 0.0146% | $5.33 | $106,600 | +15.46% | ||
| 2023-09-25 | Sale | Chief Financial Officer | 3,000 0.0022% | $6.38 | $19,140 | -3.58% | ||
| 2023-09-19 | Sale | Chief Technology Officer | 20,000 0.0148% | $6.49 | $129,800 | -2.65% | ||
| 2023-09-07 | Sale | President and CEO | 20,000 0.0146% | $6.83 | $136,600 | -7.42% | ||
| 2023-08-24 | Sale | Chief Financial Officer | 3,000 0.0021% | $7.69 | $23,070 | -15.44% | ||
| 2023-08-21 | Sale | Chief Technology Officer | 20,000 0.0148% | $8.07 | $161,400 | -20.09% | ||
| 2023-08-07 | Sale | President and CEO | 20,000 0.0145% | $9.04 | $180,800 | -27.86% | ||
| 2023-07-24 | Sale | Chief Financial Officer | 3,000 0.0022% | $9.17 | $27,510 | -27.17% | ||
| 2023-07-19 | Sale | Chief Technology Officer | 20,000 0.0147% | $8.76 | $175,200 | -23.32% |
Insider Historical Profitability
| RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner | 13381054 10.3881% | $6.52 | 21 | 0 | <0.0001% |
| Shah Rajeev M. | 13381054 10.3881% | $6.52 | 3 | 0 | <0.0001% | |
| Poirson Allen | SVP Marketing and Corp. Dev. | 40383 0.0314% | $6.52 | 1 | 0 | |
| Dion Gisele | director | 5000 0.0039% | $6.52 | 1 | 0 | |
| Ball Jack | director | 3000 0.0023% | $6.52 | 1 | 2 |
Institutional Investor Ownership
| BlackRock | $116.93M | 13.28 | 17.43M | -1.99% | -$2.37M | <0.01 | |
| Brown Capital Management | $80.67M | 9.16 | 12.02M | +0.05% | +$38,173.19 | 1.43 | |
| The Vanguard Group | $80.61M | 9.15 | 12.01M | +1.03% | +$819,324.54 | <0.01 | |
| RA Capital Management, L.P. | $45.69M | 5.19 | 6.81M | 0% | +$0 | 0.05 | |
| Hillhouse Capital Advisors Ltd | $44.67M | 5.07 | 6.66M | 0% | +$0 | 0.97 |